The safety and efficacy of the procedureless intragastric balloon

Affiliations


Abstract

Background: Obesity is on a continuous rise worldwide, and with it, novel bariatric procedures have emerged. The introduction of gastric balloons has opened up a nonsurgical option for patients opting for it. However, they still require some form of sedation and endoscopy for insertion and/or removal.

Objectives: The Elipse balloon is a novel creation that has managed to bypass both these procedures; therefore, the investigation into its effectiveness is of importance.

Setting: Royale Hayat, Sabah, and Amiri Hospitals, Kuwait.

Methods: This is a multicenter, prospective analysis of all patients who underwent the Elipse balloon insertion. For the duration of 4 months, weight, body mass index, and the occurrence of adverse events was documented.

Results: A total of 135 patients were included, with a mean age of 33.5 years. At the 4-month mark, the mean weight of the patients showed a drop of 13.0 kg (P = .000), and the mean body mass index showed a drop of 4.9 units (P = .000). The mean percent total weight loss was 15.1%. All patients reported nausea in the first day of insertion; however, 69.6% reported complete resolution by the third day. Two patients (1.5%) vomited the balloon early, 3 patients (2.2%) had to have the balloon removed early due to intolerance, 3 patients (2.2%) experienced early deflation, 18 (13.3%) patients reported episodes of diarrhea around the time of deflation, and 29 (21.5%) patients experienced colicky abdominal pain in the week of balloon deflation. One patient experienced small bowel obstruction after which the balloon was removed via laparoscopic enterotomy.

Conclusion: This study aimed to evaluate the safety and effectiveness of the Elipse balloon in the largest population studied as of date. It was also able to demonstrate that it can be safely and successfully swallowed, filled, imaged, and passed. In addition, it effectively aided in weight loss, showing promising results.

Keywords: Balloon; Bariatric; Elipse; Kuwait; precedureless.


Similar articles

The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients.

Ienca R, Al Jarallah M, Caballero A, Giardiello C, Rosa M, Kolmer S, Sebbag H, Hansoulle J, Quartararo G, Zouaghi SAS, Juneja G, Murcia S, Turro R, Pagan A, Badiuddin F, Dargent J, Urbain P, Paveliu S, di Cola RS, Selvaggio C, Al Kuwari M.Obes Surg. 2020 Sep;30(9):3354-3362. doi: 10.1007/s11695-020-04539-8.PMID: 32279182 Free PMC article.

Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study.

Machytka E, Gaur S, Chuttani R, Bojkova M, Kupka T, Buzga M, Giannakou A, Ioannis K, Mathus-Vliegen E, Levy S, Raftopoulos I.Endoscopy. 2017 Feb;49(2):154-160. doi: 10.1055/s-0042-119296. Epub 2016 Dec 12.PMID: 27951610 Clinical Trial.

The Safety and Efficacy of Procedureless Gastric Balloon: a Study Examining the Effect of Elipse Intragastric Balloon Safety, Short and Medium Term Effects on Weight Loss with 1-Year Follow-Up Post-removal.

Jamal MH, Almutairi R, Elabd R, AlSabah SK, Alqattan H, Altaweel T.Obes Surg. 2019 Apr;29(4):1236-1241. doi: 10.1007/s11695-018-03671-w.PMID: 30613935 Clinical Trial.

Intragastric Balloon (BIB system) in the treatment of obesity and preparation of patients for surgery - own experience and literature review.

Dąbrowiecki S, Szczęsny W, Popławski C, Sosnowski D.Pol Przegl Chir. 2011 Apr;83(4):181-7. doi: 10.2478/v10035-011-0028-2.PMID: 22166356 Review.

Endoscopic Balloon Therapy.

Klingler MJ, Kroh M.Surg Clin North Am. 2021 Apr;101(2):355-371. doi: 10.1016/j.suc.2020.12.009.PMID: 33743974 Review.


Cited by

Factors Affecting Weight Reduction after Intragastric Balloon Insertion: A Retrospective Study.

Bawahab MA, Abbas KS, Maksoud WMAE, Abdelgadir RS, Altumairi K, Alqahtani AR, Alzahrani HA, Bhat MJ.Healthcare (Basel). 2023 Feb 17;11(4):600. doi: 10.3390/healthcare11040600.PMID: 36833134 Free PMC article.

Endoscopic bariatrics: current therapies and future directions.

Reja D, Zhang C, Sarkar A.Transl Gastroenterol Hepatol. 2022 Apr 25;7:21. doi: 10.21037/tgh.2020.03.09. eCollection 2022.PMID: 35548475 Free PMC article. Review.

A Randomized, Controlled Trial Comparing the Impact of a Low-Calorie Ketogenic vs a Standard Low-Calorie Diet on Fat-Free Mass in Patients Receiving an Elipse™ Intragastric Balloon Treatment.

Schiavo L, De Stefano G, Persico F, Gargiulo S, Di Spirito F, Griguolo G, Petrucciani N, Fontas E, Iannelli A, Pilone V.Obes Surg. 2021 Apr;31(4):1514-1523. doi: 10.1007/s11695-020-05133-8. Epub 2020 Nov 20.PMID: 33215362 Free PMC article. Clinical Trial.

Ultrasound-guided insertion of the Elipse® gastric balloon: technical details, learning curve, and perioperative outcome in 36 cases.

Salmi A, Greco F, Belleri E.J Ultrasound. 2020 Dec;23(4):593-597. doi: 10.1007/s40477-020-00499-y. Epub 2020 Jul 3.PMID: 32621121 Free PMC article.

Procedures and devices for bariatric and metabolic endoscopy.

Orlandini B, Gallo C, Boškoski I, Bove V, Costamagna G.Ther Adv Gastrointest Endosc. 2020 Jun 3;13:2631774520925647. doi: 10.1177/2631774520925647. eCollection 2020 Jan-Dec.PMID: 32548577 Free PMC article. Review.


KMEL References